We are live on !
Find out more
M.D. Sass Portfolio holdings
AUM
$3.31B
Turnover
9.52%
1-Year Est. Return
22.27%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+22.27%
3 Year Est. Return
+76.78%
5 Year Est. Return
+94.03%
10 Year Est. Return
+298.99%
AUM
$1.19B
AUM Growth
-$336M
(-22%)
Cap. Flow
-$519M
Cap. Flow % of AUM
Cap. Flow %
-43.47%
Top 10 Holdings %
Top 10 Hldgs %
47.76%
Holding
60
New
9
Increased
5
Reduced
31
Closed
8
Avg Time Held
Equity + Options
1.5
years
Top 10 Avg Time Held
Equity + Options
0.9
years
Top 20 Avg Time Held
Equity + Options
1.4
years
Avg Time Held Equity only
1.6
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$34.4M |
| 2 |
Comcast
CMCSA
|
+$34.4M |
| 3 |
LVNTA
Liberty Interactive Series A Liberty Ventures
LVNTA
|
+$29.1M |
| 4 |
Qorvo
QRVO
|
+$18.8M |
| 5 |
Snap-on
SNA
|
+$17.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$50.8M |
| 2 |
CELG
Celgene
CELG
|
+$35.4M |
| 3 |
Royal Caribbean
RCL
|
+$32M |
| 4 |
Discover Financial Services
DFS
|
+$31.1M |
| 5 |
Gaming and Leisure Properties
GLPI
|
+$30.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.83% |
| 2 | Miscellaneous | 15.44% |
| 3 | Financials | 13.02% |
| 4 | Technology | 12.43% |
| 5 | Consumer Discretionary | 10.27% |
Similar funds
BG
M.D. Sass's Q3 2017 Portfolio in Review
As of Q3 2017, M.D. Sass held 60 positions worth $1.19B, down 22% from $1.53B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
M.D. Sass withdrew a net $519M in Q3 2017, closing 8 positions and reducing 31 holdings. Its most notable exit was Anadarko Petroleum, an estimated $25M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, M.D. Sass opened a new position in Teradyne worth $37.1M.
- M.D. Sass's largest Q3 2017 buy was Teradyne: 994,850 shares worth $37.1M.
- M.D. Sass added most to Keysight in Q3 2017, an estimated $12.2M increase.
- M.D. Sass's biggest Q3 2017 reduction was Cognizant, cutting an estimated $50.8M.
- M.D. Sass fully exited Anadarko Petroleum in Q3 2017, selling an estimated $25M.
- M.D. Sass's ten largest holdings make up 48% of its $1.19B portfolio in Q3 2017.
- M.D. Sass opened 9 new positions and closed 8 in Q3 2017.
- M.D. Sass's portfolio value fell 22% quarter-over-quarter to $1.19B.
Based on M.D. Sass's 13F filing for Q3 2017, filed 13 Nov 2017.